Human tankyrases 1 and 2 (TNKS1/2) are attractive pharmacological biotargets, especially for the treatment of specific types of cancer. This article provides a fairly comprehensive overview of the structural biology of the TNKS-inhibitor complex and the current medicinal chemistry strategies being used in the structure-based rational design of tankyrase-specific inhibitors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c4mb00385c | DOI Listing |
Publication Analysis
Top Keywords
structure-based rational
8
rational design
8
advances structure-based
4
design tnksis
4
tnksis human
4
human tankyrases
4
tankyrases tnks1/2
4
tnks1/2 attractive
4
attractive pharmacological
4
pharmacological biotargets
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!